• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

华致柔肝颗粒通过诱导自噬减轻非酒精性脂肪性肝病细胞模型中的脂肪变性

[Huazhi Rougan Granules attenuates steatosis in cell model of nonalcoholic fatty liver disease by inducing autophagy].

作者信息

Shi Ya-Min, Fu Zhi-Hui, Zhu Chun-Sheng, Li Xiao-Ping

机构信息

the First Affiliated Hospital of Zhengzhou University Zhengzhou 450052, China.

出版信息

Zhongguo Zhong Yao Za Zhi. 2023 Apr;48(7):1770-1778. doi: 10.19540/j.cnki.cjcmm.20221111.401.

DOI:10.19540/j.cnki.cjcmm.20221111.401
PMID:37282951
Abstract

To investigate the effect of Huazhi Rougan Granules(HZRG) on autophagy in a steatotic hepatocyte model of free fatty acid(FFA)-induced nonalcoholic fatty liver disease(NAFLD) and explore the possible mechanism. FFA solution prepared by mixing palmitic acid(PA) and oleic acid(OA) at the ratio of 1∶2 was used to induce hepatic steatosis in L02 cells after 24 h treatment, and an in vitro NAFLD cell model was established. After termination of incubation, cell counting kit-8(CCK-8) assay was performed to detect the cell viability; Oil red O staining was employed to detect the intracellular lipid accumulation; enzyme-linked immunosorbnent assay(ELISA) was performed to measure the level of triglyceride(TG); to monitor autophagy in L02 cells, transmission electron microscopy(TEM) was used to observe the autophagosomes; LysoBrite Red was used to detect the pH change in lysosome; transfection with mRFP-GFP-LC3 adenovirus was conducted to observe the autophagic flux; Western blot was performed to determine the expression of autophagy marker LC3B-Ⅰ/LC3B-Ⅱ, autophagy substrate p62 and silent information regulator 1(SIRT1)/adenosine 5'-monophosphate(AMP)-activated protein kinase(AMPK) signaling pathway. NAFLD cell model was successfully induced by FFA at 0.2 mmol·L(-1) PA and 0.4 mmol·L(-1) OA. HZRG reduced the TG level(P<0.05, P<0.01) and the lipid accumulation of FFA-induced L02 cells, while elevated the number of autophagosomes and autophagolysosomes to generate autophagic flux. It also affected the functions of lysosomes by regulating their pH. Additionally, HZRG up-regulated the expression of LC3B-Ⅱ/LC3B-Ⅰ, SIRT1, p-AMPK and phospho-protein kinase A(p-PKA)(P<0.05, P<0.01), while down-regulated the expression of p62(P<0.01). Furthermore, 3-methyladenine(3-MA) or chloroquine(CQ) treatment obviously inhibited the above effects of HZRG. HZRG prevented FFA-induced steatosis in L02 cells, and its mechanism might be related to promoting autophagy and regulating SIRT1/AMPK signaling pathway.

摘要

探讨化脂柔肝颗粒(HZRG)对游离脂肪酸(FFA)诱导的非酒精性脂肪性肝病(NAFLD)脂肪变性肝细胞模型自噬的影响,并探究其可能机制。将棕榈酸(PA)和油酸(OA)按1∶2比例混合配制的FFA溶液用于处理L02细胞24小时以诱导肝脂肪变性,从而建立体外NAFLD细胞模型。孵育结束后,采用细胞计数试剂盒-8(CCK-8)法检测细胞活力;用油红O染色检测细胞内脂质蓄积;采用酶联免疫吸附测定(ELISA)法测定甘油三酯(TG)水平;为监测L02细胞中的自噬,使用透射电子显微镜(TEM)观察自噬体;用溶酶体荧光探针LysoBrite Red检测溶酶体pH变化;进行mRFP-GFP-LC3腺病毒转染以观察自噬通量;采用蛋白质免疫印迹法检测自噬标志物LC3B-Ⅰ/LC3B-Ⅱ、自噬底物p62以及沉默信息调节因子1(SIRT1)/5'-单磷酸腺苷(AMP)激活的蛋白激酶(AMPK)信号通路的表达。0.2 mmol·L⁻¹ PA和0.4 mmol·L⁻¹ OA的FFA成功诱导了NAFLD细胞模型。HZRG降低了TG水平(P<0.05,P<0.01)以及FFA诱导的L02细胞的脂质蓄积,同时增加了自噬体和自噬溶酶体的数量以产生自噬通量。它还通过调节溶酶体pH来影响溶酶体功能。此外,HZRG上调了LC3B-Ⅱ/LC3B-Ⅰ、SIRT1、磷酸化AMPK(p-AMPK)和磷酸化蛋白激酶A(p-PKA)的表达(P<0.05,P<0.01),而下调了p62的表达(P<0.01)。此外,3-甲基腺嘌呤(3-MA)或氯喹(CQ)处理明显抑制了HZRG的上述作用。HZRG可预防FFA诱导的L02细胞脂肪变性,其机制可能与促进自噬和调节SIRT1/AMPK信号通路有关。

相似文献

1
[Huazhi Rougan Granules attenuates steatosis in cell model of nonalcoholic fatty liver disease by inducing autophagy].华致柔肝颗粒通过诱导自噬减轻非酒精性脂肪性肝病细胞模型中的脂肪变性
Zhongguo Zhong Yao Za Zhi. 2023 Apr;48(7):1770-1778. doi: 10.19540/j.cnki.cjcmm.20221111.401.
2
[Liraglutide alleviates lipotoxic liver cell damage and promotes autophagy to improve non-alcoholic fatty liver].利拉鲁肽减轻脂毒性肝细胞损伤并促进自噬以改善非酒精性脂肪肝
Zhonghua Gan Zang Bing Za Zhi. 2021 May 20;29(5):456-461. doi: 10.3760/cma.j.cn501113-20200427-00219.
3
LB100 ameliorates nonalcoholic fatty liver disease the AMPK/Sirt1 pathway.LB100 通过 AMPK/Sirt1 通路改善非酒精性脂肪性肝病。
World J Gastroenterol. 2019 Dec 7;25(45):6607-6618. doi: 10.3748/wjg.v25.i45.6607.
4
GLP-1 analogue improves hepatic lipid accumulation by inducing autophagy via AMPK/mTOR pathway.胰高血糖素样肽-1类似物通过AMPK/mTOR途径诱导自噬来改善肝脏脂质积累。
Biochem Biophys Res Commun. 2016 Aug 5;476(4):196-203. doi: 10.1016/j.bbrc.2016.05.086. Epub 2016 May 18.
5
Liraglutide reduces lipid accumulation in steatotic L‑02 cells by enhancing autophagy.利拉鲁肽通过增强自噬减少脂肪变性L-02细胞中的脂质积累。
Mol Med Rep. 2014 Nov;10(5):2351-7. doi: 10.3892/mmr.2014.2569. Epub 2014 Sep 15.
6
Resveratrol improves hepatic steatosis by inducing autophagy through the cAMP signaling pathway.白藜芦醇通过环磷酸腺苷(cAMP)信号通路诱导自噬来改善肝脂肪变性。
Mol Nutr Food Res. 2015 Aug;59(8):1443-57. doi: 10.1002/mnfr.201500016. Epub 2015 May 28.
7
A novel combination of metformin and resveratrol alleviates hepatic steatosis by activating autophagy through the cAMP/AMPK/SIRT1 signaling pathway.二甲双胍和白藜芦醇的新组合通过 cAMP/AMPK/SIRT1 信号通路激活自噬来减轻肝脂肪变性。
Naunyn Schmiedebergs Arch Pharmacol. 2023 Nov;396(11):3135-3148. doi: 10.1007/s00210-023-02520-7. Epub 2023 May 20.
8
Prolyl Oligopeptidase Inhibition Attenuates Steatosis in the L02 Human Liver Cell Line.脯氨酰寡肽酶抑制可减轻L02人肝细胞系中的脂肪变性。
PLoS One. 2016 Oct 19;11(10):e0165224. doi: 10.1371/journal.pone.0165224. eCollection 2016.
9
Inhibitory Effect of Styrylpyrone Extract of on Hepatic Steatosis in HepG2 Cells.姜黄素对 HepG2 细胞脂肪变性的抑制作用。
Int J Mol Sci. 2023 Feb 12;24(4):3672. doi: 10.3390/ijms24043672.
10
miR-122 promotes hepatic lipogenesis via inhibiting the LKB1/AMPK pathway by targeting Sirt1 in non-alcoholic fatty liver disease.miR-122 通过靶向 Sirt1 抑制 LKB1/AMPK 通路促进非酒精性脂肪性肝病中的肝脂肪生成。
Mol Med. 2019 Jun 13;25(1):26. doi: 10.1186/s10020-019-0085-2.